Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug th-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma
GHK-Cu 100mg is designed for laboratory research involving copper peptide activity, extracellular matrix pathway behavior, collagen-associated pathway models, peptide-metal complex research, cellular response analysis, and structure-function evaluation
*Based on a clinical study conducted with 36 volunteers by an independent lab in September 2025 Aqua, 3-O- Ethyl ascorbic acid, Propanediol, Propylene glycol, Betaine, Glycerin, Glyceryl Glucoside, Glutathione, Phenoxyethanol, Squalane, Sodium Acrylates Copolymer, Lecithin, Undecylenoyl Phenylalanine, Allantoin, Tocopherol, Carbomer, Ethylhexylglycerin, Octenidine HCl, Disodium EDTA, Triethanolamine, Allergen free fragrance Aqua, 3-O- Ethyl ascorbic acid, Propanediol, Propylene glycol, Betaine, Glycerin, Glyceryl Glucoside, Glutathione, Phenoxyethanol, Squalane, Sodium Acrylates Copolymer, Lecithin, Undecylenoyl Phenylalanine, Allantoin, Tocopherol, Carbomer, Ethylhexylglycerin, Octenidine HCl, Disodium EDTA, Triethanolamine, Allergen free fragrance Vegan Paraben Free Dermatologically Tested Cruelty Free Sulfate Free Users see visible brightening and reduced dark spots within 2-3 weeks of consistent daily use
5.3 Microbiome-based and coagulation biomarkers Microbiome profiling and coagulation factors have emerged as promising non-invasive diagnostic candidates for endometriosis, offering potential insights into disease pathogenesis and clinical management
